KMO - kynurenine 3-monooxygenase Gene

Homo sapiens

Also known as dJ317G22.1

Gene ID: 8564 | Gene type: protein coding

About KMO

Cytogenetic location: 1q43 Genomic coordinates (GRCh38): 1:241,532,378-241,595,642 (from NCBI)

This gene has 10 transcripts (splice variants), 208 orthologues and 1 paralogue. Broad expression in liver (RPKM 11.5), kidney (RPKM 9.8) and 20 other tissues.

Summary

This gene encodes a mitochondrion outer membrane protein that catalyzes the hydroxylation of L-tryptophan metabolite, L-kynurenine, to form L-3-hydroxykynurenine. Studies in yeast identified this gene as a therapeutic target for Huntington disease. [provided by RefSeq, Oct 2011]

KMO Products(2)

mRNA	Protein	Name
NM_001410944.1	NP_001397873.1	kynurenine 3-monooxygenase isoform 2
NM_003679.5	NP_003670.2	kynurenine 3-monooxygenase isoform 1

KMO Protein Structure

FAD_binding_3

0
100
200
300
400
486 a.a.

Protein Preferred Names

Protein Names

kynurenine 3-monooxygenase

kynurenine 3-hydroxylase

Related Diseases

Diseases

Alias

Transient Cerebral Ischemia

Transient Ischemic Attack	Transient Ischemic Attacks
Tia	Tia - Transient Ischaemic Attack
Transient Cerebral Ischaemia	Ischemic Attack, Transient
Intermittent Cerebral Ischemia	Tia - [Transient Ischaemic Attack]
Intermittent Cerebral Ischaemia	Transient Cerebral Ischaemic Attack, Unspecified, Course Of Resolution Unspecified

Streptococcal Meningitis

Huntington Disease

Huntington'S Disease	Huntington Chorea
Huntington'S Chorea	HD
Huntington Chronic Progressive Hereditary Chorea	Juvenile Huntington Disease
Chronic Progressive Chorea	Chronic Progressive Hereditary Chorea
Hc - [Huntington Chorea]	Hereditary Chorea
Progressive Hereditary Chorea

Intracranial Vasospasm

Vasospasm, Intracranial

Dystonia

Dystonic Disease	Dystonic Disorder
Dystonia Disorders	Neuroleptic Dyskinesia

Schizophrenia

SCZD	Schizophrenia With Or Without An Affective Disorder
Schizophrenia 12	Schizophrenia, Susceptibility To
Schizophrenia-1	Dementia Praecox
Schizophrenia 1

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Pre-clinical Phase

Bioactive Molecules (7)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-112179	GSK180	Inhibitor	99.04%	Unkown
HY-15600	UPF-648	Inhibitor	99.87%	Unkown
HY-119171	GSK 366	Inhibitor	99.80%	Unkown
HY-W748591	Cannflavin A		99.20%	Unkown
HY-15500	JM6		/	Unkown
HY-RS07400	KMO Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-15600B	UPF-648 sodium salt	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Mus musculus	KMO	MGD	MGI:2138151
Macaca mulatta	KMO	VGNC	VGNC:74197
Canis familiaris	KMO	VGNC	VGNC:42488
Rattus norvegicus	KMO	RGD	RGD:620610
Bos taurus	KMO	VGNC	VGNC:30689
Felis catus	KMO	VGNC	VGNC:67970

Name
Email *

	Sorry, but the email address you supplied was invalid.